Published in
American Association for the Advancement of Science, Science Advances, 5(6), 2020
Links
Tools
Retinoid X receptor alpha is a spatiotemporally predominant therapeutic target for anthracycline-induced cardiotoxicity
Journal article published in 2020 by
Xiao Ma 
,
Ping Zhu,
Yonghe Ding,
Hong Zhang ,
Qi Qiu ,
Alexey V. Dvornikov ,
Zheng Wang ,
Maengjo Kim,
Yong Wang,
Matthew Lowerison ,
Yue Yu,
Nadine Norton,
Joerg Herrmann,
Stephen C. Ekker ,
Tzung K. Hsiai
and other authors.
,
Ping Zhu,
Yonghe Ding,
Hong Zhang ,
Qi Qiu ,
Alexey V. Dvornikov ,
Zheng Wang ,
Maengjo Kim,
Yong Wang,
Matthew Lowerison ,
Yue Yu,
Nadine Norton,
Joerg Herrmann,
Stephen C. Ekker ,
Tzung K. Hsiai
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Postprint:
archiving forbidden
Data provided by 
Abstract
RXRA is an endothelial- and early stage–predominant therapeutic target for treating anthracycline-induced cardiotoxicity.